Akums posts strong FY26 performance as EBITDA surges 61.6% in Q4

Merck KGaA raises 2026 outlook as life science & AI chip boom power strong Q1 growth

The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion

FDA okays RIVANNA’s AI-powered Accuro XV ultrasound system

The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging

Symeres appoints Henning Steinhagen as CEO to drive next phase of global growth

Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector

Lupin Q4 FY26 PBT jumps 115% to Rs 19,280 million

U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit

Govt. launches JANANI platform to strengthen maternal and child healthcare tracking

Digital platform records over 1.34 crore beneficiary registrations with QR-enabled MCH cards and real-time monitoring features

Dabur profit jumps 16% as FMCG growth gains pace

Hair care & quick commerce shine

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical

Laurus Labs Q4 profit rises to Rs. 279 crore, FY26 revenue up 23%

The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms

Emcure crosses US$1 billion revenue milestone in FY26; PAT rises 33%

Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth